Third Harmonic Bio Inc CEO Natalie Holles Sells 13,558 Shares
Yahoo FinanceApr 15 19:00 ET
Third Harmonic Bio(THRD.US) Officer Sells US$165.21K in Common Stock
$Third Harmonic Bio(THRD.US)$ Officer Holles Natalie C. sold 13,558 shares of common stock on Apr 11, 2024 at an average price of $12.1857 for a total value of $165.21K.Source: Announcement What is st
moomoo NewsApr 15 16:58 ET
Third Harmonic Bio(THRD.US) Officer Sells US$11,070 in Common Stock
$Third Harmonic Bio(THRD.US)$ Officer Person Julie sold 1,107 shares of common stock on Apr 4, 2024 at an average price of $10 for a total value of $11,070.Source: Announcement What is statement of ch
moomoo NewsApr 8 18:02 ET
We're Not Worried About Third Harmonic Bio's (NASDAQ:THRD) Cash Burn
Yahoo FinanceApr 8 12:41 ET
Here's Why We're Not At All Concerned With Third Harmonic Bio's (NASDAQ:THRD) Cash Burn Situation
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, Third Harmonic Bio (NASDAQ:THRD) shareholders have done very well over the last year, with the share
Simply Wall StApr 6 09:30 ET
Third Harmonic Bio Welcomes New Director, Geoff McDonough
TipRanksMar 28 17:02 ET
Third Harmonic Bio Inc (THRD) Reports Decreased Net Loss in Q4, Aligns With Analyst Projections
Yahoo FinanceMar 26 21:02 ET
Third Harmonic Bio GAAP EPS of -$2.45 Misses by $1.20
Seeking AlphaMar 26 15:36 ET
Buy Rating for Third Harmonic Bio Amidst Promising Drug Pipeline and Market Potential
TipRanksMar 26 14:15 ET
TD Cowen Remains a Buy on Third Harmonic Bio, Inc. (THRD)
TipRanksMar 26 10:16 ET
Express News | Third Harmonic Bio Q4 EPS $(0.17) Beats $(0.31) Estimate
Moomoo 24/7Mar 26 09:26 ET
Recap: Third Harmonic Bio Q4 Earnings
Third Harmonic Bio (NASDAQ:THRD) reported its Q4 earnings results on Tuesday, March 26, 2024 at 08:05 AM.Here's what investors need to know about the announcement.EarningsThird Harmonic Bio beat estim
BenzingaMar 26 09:25 ET
Express News | Third Harmonic Bio Reported Q4 Net Loss of $(6.8)M, Cash Balance of $269.1M
Moomoo 24/7Mar 26 08:14 ET
Third Harmonic Bio 4Q EPS 78c >THRD
Third Harmonic Bio 4Q EPS 78c >THRD
Dow JonesMar 26 08:05 ET
Third Harmonic Bio to Participate in the 44th Annual TD Cowen Health Care Conference
SAN FRANCISCO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (NASDAQ:THRD), a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases, today announced that Chief
GlobeNewswireFeb 26 16:00 ET
Third Harmonic Bio Taps Horizon Therapeutics Alum for Finance Chief
By Dean Seal Third Harmonic Bio has hired a former group vice president at Horizon Therapeutics to be its next chief financial officer. The biopharmaceutical company said Thursday that Christopher M
WSJJan 4 08:17 ET
Third Harmonic Bio: IND-enabling Toxicology Studies of THB335 Nearing Completion; Pre-IND Interaction With the U.S. FDA Now Complete >THRD
Third Harmonic Bio: IND-enabling Toxicology Studies of THB335 Nearing Completion; Pre-IND Interaction With the U.S. FDA Now Complete >THRD
Dow JonesJan 4 08:04 ET
Third Harmonic Bio: Program Remains on Track to File a U.S. IND and Initiate a Phase 1 Study of THB335 During the 1H of 2024 >THRD
Third Harmonic Bio: Program Remains on Track to File a U.S. IND and Initiate a Phase 1 Study of THB335 During the 1H of 2024 >THRD
Dow JonesJan 4 08:04 ET
Third Harmonic Bio Appoints Christopher Murphy as Chief Fincl >THRD
Third Harmonic Bio Appoints Christopher Murphy as Chief Fincl >THRD
Dow JonesJan 4 08:03 ET
Are You Looking for a Top Momentum Pick? Why Third Harmonic Bio, Inc. (THRD) Is a Great Choice
Yahoo FinanceDec 29, 2023 12:00 ET
No Data
No Data